Searched for
DANISH BIOTECH
Mark Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapyLast October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development of the therap...- Weight-loss treatment: How has obesity medicine market become battleground for pharma giants like Pfizer, AstraZeneca, Eli Lilly?Obesity, weight-loss medicines: Novo has been scrambling to keep pace in the obesity drug race it started, losing ground to rival Eli Lilly...
- Genmab to buy Dutch cancer drugmaker Merus for $8 billionDenmark's Genmab has agreed to acquire Dutch biotech Merus NV for $8 billion in cash, adding the head-and-neck cancer drug petosemtamab to ...
- Patanjali Foods, Prestige Estates among 13 dividend stocks to watch: Last day to buyInvestors eyeing dividend payouts should note today is the last day to buy shares of Patanjali Foods and Prestige Estates Projects to quali...
- Novo Nordisk inks $2-billion obesity drug deal with United LabsNovo will pay Hong Kong-based United Laboratories $200 million upfront for the drug, which combines three different mechanisms in an effort...
- Bavarian Nordic inks Mpox vaccine deal with Serum InstituteBavarian Nordic A/S partnered with the Serum Institute of India to produce its mpox vaccine. The Serum Institute will supply the Indian mar...
- Novo Nordisk shares drop more than 4% on disappointing obesity pill dataShares were down 4.3% at 1330 GMT, the lowest since August 8, after the company announced headline results from its trial of monlunabant, a...
- Bavarian Nordic shares up 45% this week on mpox outbreakBiotech firm Bavarian Nordic shares soared over 15% on Friday, another day of substantial gains which analysts have linked to the outbreak ...
- Novo Nordisk to buy Cardior Pharma for up to $1 billionNovo Nordisk A/S bought Cardior Pharmaceuticals for $1 billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies...
- Eli Lilly could launch obesity drug in India next year, CEO saysEli Lilly plans to launch its diabetes and obesity drug, Mounjaro, in India next year. The drug contains tirzepatide and is sold as Zepboun...
- Miners drag European bourses lower as energy crisis loomsThe energy sub-index firmed 0.2% to extend gains to seventh straight day.Investors were cautious ahead of the Jackson Hole symposium after ...
- Carlsberg, Nirma, PEs in race for bottlemaker HNGDanish beer maker Carlsberg, private equity funds Oaktree Capital and Cerberus, Nirma Chemicals and SNJ Distilleries are among a dozen enti...
- Djokovic bets on Danish COVID-19 cure as he quests for tennis historyQuantBioRes boss Ivan Loncarevic, who described himself as an entrepreneur, said the tennis player's acquisition of the 80% stake was made ...
- GS Krishnan takes over as new 'ABLE' PresidentGS Krishnan, formerly regional president & MD, Novozymes South Asia Pvt Ltd, a Danish biotech company, has taken charge as the new Presiden...
- US drugmaker Bristol Myers Squibb out of Biocon’s oral insulin projectBMS had taken a wider decision to sell its entire diabetes franchise to British drug maker AstraZeneca, while narrowing its own focus on de...
- Genmab inks $1.1 bn deal with Johnson & JohnsonDanish pharma firm Genmab has said that it had reached a deal worth up to $1.1 bn with US drug giant Johnson & Johnson.
- Novozymes sets up Indo-Danish biotech exchange programWith a population of 1.3 billion, more than 500 universities and more than 12 million students, India is increasingly seen as a global supe...
- MOIA in labour agreement with DenmarkThe ministry of overseas Indian affairs has inked a comprehensive labour mobility partnership with the government of Denmark which provides...
- Biocon picks up 70% in German pharma co AxiCorp for e30 mnThe deal will enable the Bangalore-based player to market its injectible insulin, generics, biosimilars and biologics in Europe.
- Biocon to outlicense molecules to fund R&DBiotech company Biocon is in talks with various companies to outlicense some of its molecules to fund increasing investment in the research...
Load More
